Certified by Founder Lodge 
                                        
                                        Manifold Bio
 United States  -  Boston, Massachusetts
 
                                                 United States  -  Boston, Massachusetts 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $40,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                2020 
- 
                                                Operating Status 
                                                Active 
- 
                                                Last Funding Type 
                                                Seed 
- 
                                                Company Type 
                                                For Profit 
- Website
- Contact
- Social Links
                                            A next-generation protein therapeutics company pioneering an in vivo biologics design platform. By redesigning in vivo measurement to be available from day one, Manifold Bio has an advantage 
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| July, 14 ,2022 | Series A | $40,000,000 | 
 
                                                 Playground Global
 Playground Global
                                                                                 Section 32
 Section 32
                                                                                 FPV Ventures
 FPV Ventures
                                                                                 Horizons Ventures
 Horizons Ventures
                                                                                 
                                                                             Triatomic Capital
 Triatomic Capital
                                                                                 Fifty Years
 Fifty Years
                                                                                 IDRx
IDRx CAMP4 Therapeutics
CAMP4 Therapeutics Delfi Diagnostics
Delfi Diagnostics xilis
xilis Scorability |  $11,000,000  | (Oct 18, 2023)
                                                                        
                                Scorability |  $11,000,000  | (Oct 18, 2023) Hallmark Health Care Solutions |  Undisclosed Amount  | (Oct 18, 2023)
                                                                        
                                Hallmark Health Care Solutions |  Undisclosed Amount  | (Oct 18, 2023) Cloover |  $7,388,000  | (Oct 18, 2023)
                                                                        
                                Cloover |  $7,388,000  | (Oct 18, 2023) 
                             Yardstik |  $12,000,000  | (Oct 18, 2023)
                                                                        
                                Yardstik |  $12,000,000  | (Oct 18, 2023) Anonybit |  $3,000,000  | (Oct 18, 2023)
                                                                        
                                Anonybit |  $3,000,000  | (Oct 18, 2023) 
                                                 
                                                 
                                                 
                                                     
                                                 
                                                 
                                                     
                                                 
                                                 
                                                 
                                                